| Abstrakt: |
Blood Platelet Disorders, Health and Medicine, Hematologic Diseases and Conditions, Hematology, Hemic and Lymphatic Diseases and Conditions, Hemolytic, Hemolytic Anemia, Hemolytic Uremic Syndrome, Kidney Diseases and Conditions, Pediatrics, Quality of Life, Thrombocytopenia, Thrombotic Microangiopathies According to the news editors, the research concluded: "Adult patients and caregivers of pediatric patients indicated an overall preference for ravulizumab than eculizumab for the treatment of aHUS, driven primarily by infusion frequency. Keywords: Blood Platelet Disorders; Health and Medicine; Hematologic Diseases and Conditions; Hematology; Hemic and Lymphatic Diseases and Conditions; Hemolytic; Hemolytic Anemia; Hemolytic Uremic Syndrome; Kidney Diseases and Conditions; Pediatrics; Quality of Life; Thrombocytopenia; Thrombotic Microangiopathies EN Blood Platelet Disorders Health and Medicine Hematologic Diseases and Conditions Hematology Hemic and Lymphatic Diseases and Conditions Hemolytic Hemolytic Anemia Hemolytic Uremic Syndrome Kidney Diseases and Conditions Pediatrics Quality of Life Thrombocytopenia Thrombotic Microangiopathies 593 593 1 08/14/23 20230817 NES 230817 2023 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Research findings on hemolytic uremic syndrome are discussed in a new report. [Extracted from the article] |
